BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531752

BIOGEN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Biogen Pharmachem Industries Share Price Update

As of the latest trading session, Biogen Pharmachem Industries share price is currently at ₹ 0.91, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 0.91 and ₹ 0.93. Over the past year, Biogen Pharmachem Industries has achieved a return of -29.77 %. In the last month alone, the return has been -1.07 %. Read More...

Investment Returns

Over 1 Month -1.07% Over 3 Months -4.16% Over 6 Months -12.38% Over 1 Year -29.77%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Biogen Pharmachem Industries fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    83.90

  • P/E Ratio (TTM)

    92.00

  • Beta

    0.54

  • Book Value / share

    1.48

  • Return on equity

    0.52%

  • EPS (TTM)

    0.01

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    1.34

info icon alternate text

Biogen Pharmachem Industries Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.20
Net Profit 1.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 1.34
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.17
Net Profit 1.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 1.18
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.54
Net Profit -0.31
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.31
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.35
Net Profit -1.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -1.00
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.16
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 1.13
Net Profit -0.29
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.29
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.45
Net Profit 1.93
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA 1.93
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.46
Net Profit 0.46
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.46
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 2.47
Operating Expense 2.18
Net Profit -0.01
Net Profit Margin (%) -0.40
Earnings Per Share (EPS) 0.00
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 1.62
Operating Expense 1.62
Net Profit -1.60
Net Profit Margin (%) -98.76
Earnings Per Share (EPS) -0.02
EBITDA -1.60
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.87
ROE % 0.52
ROCE % 0.55
Total Debt to Total Equity 0.00
EBITDA Margin 15.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.84
ROE % -0.34
ROCE % -0.34
Total Debt to Total Equity 0.00
EBITDA Margin -21.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -0.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -98.77
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.85
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 56.82
Total Liabilities 56.82
Total Equity 56.52
Share Outstanding 652603000
Price to Book Ratio 1.22
Return on Assets (%) 3.39
Return on Capital (%) 3.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 54.82
Total Liabilities 54.82
Total Equity 54.58
Share Outstanding 652603000
Price to Book Ratio 0.70
Return on Assets (%) 0.83
Return on Capital (%) 0.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 54.94
Total Liabilities 54.94
Total Equity 54.13
Share Outstanding 652603000
Price to Book Ratio 1.69
Return on Assets (%) -0.01
Return on Capital (%) -0.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 54.25
Total Liabilities 54.25
Total Equity 54.14
Share Outstanding 652603000
Price to Book Ratio 0.25
Return on Assets (%) -2.95
Return on Capital (%) -2.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 56.09
Total Liabilities 56.09
Total Equity 55.74
Share Outstanding 652603000
Price to Book Ratio 0.22
Return on Assets (%) -0.20
Return on Capital (%) -0.21
Particulars MAR 2024 (Values in Cr)
Net Income 1.93
Cash from Operations 1.94
Cash from Investing -2.05
Cash from Financing 0.00
Net change in Cash -0.11
Free Cash Flow 1.94
Particulars MAR 2023 (Values in Cr)
Net Income 0.45
Cash from Operations 1.70
Cash from Investing -1.65
Cash from Financing 0.00
Net change in Cash 0.04
Free Cash Flow 1.70
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 1.39
Cash from Investing -1.32
Cash from Financing 0.00
Net change in Cash 0.07
Free Cash Flow 1.39
Particulars MAR 2021 (Values in Cr)
Net Income -1.60
Cash from Operations 3.94
Cash from Investing -3.63
Cash from Financing -0.30
Net change in Cash 0.00
Free Cash Flow 3.94
Particulars MAR 2020 (Values in Cr)
Net Income -0.11
Cash from Operations -1.21
Cash from Investing 1.53
Cash from Financing -0.32
Net change in Cash 0.00
Free Cash Flow -1.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 3345.30 24.44 2.11 257.59 1468.10 / 3974.00
BAJAJ HOLDINGS & INVS LTD 13697.45 21.91 2.43 152438.92 9686.30 / 14873.20
TATA INVESTMENT CORP LTD 6952.20 107.47 1.13 35174.86 5147.15 / 8075.90
MAX FINANCIAL SERV LTD 1657.00 210.01 10.84 57185.52 972.55 / 1675.05
Naperol Investments Limited 1437.10 23.31 0.90 825.90 801.00 / 2041.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 3345.30 24.79 2.36 257.59 1468.10 / 3974.00
ARAVALI SECURITIES & FINANCE L 4.56 0.00 -7.44 6.91 3.44 / 7.37
Bagalkot Udyog Ltd 23.90 0.00 -27.43 20.32 0.00 / 0.00
BAJAJ HOLDINGS & INVS LTD 13697.45 104.29 7.86 152438.92 9686.30 / 14873.20

Biogen Pharmachem Industries Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.91 -1.08 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 0.90
  • 26 Days 0.90
  • 10 Days 0.90
  • 50 Days 0.90
  • 12 Days 0.90
  • 100 Days 1.00
  • 20 Days 0.90
  • 200 Days 1.00
0.92 PIVOT

First Support

0.90

First Resistance

0.93

Second Support

0.89

Second Resistance

0.95

Third Support

0.87

Third Resistance

0.96

RSI

48.98

ADX

17.06

MACD

-0.01

Williams % R

-28.57

Commodity Channel Index (CCI)

-43.67

Date

2025-08-21

Week

472961.00

Same Day

370332.00

Month

697795.00

1 Year

0.55

3 Year

0.68

Over 1 Month

-1.07%

down

Over 1 Year

-29.77%

down

Over 3 Months

-4.16%

down

Over 3 Years

-0.71%

down

Over 6 Months

-12.38%

down

Over 5 Years

34.37%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Biogen Pharmachem Industries shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Biogen Pharmachem Industries corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
15 Jul 2003 10.0 1.0 21 Jul 2003

Biogen Pharmachem Industries Share Price

Biogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July, 1995. The name of the Company was changed to Sun Techno Overseas Limited in August 2011 and again the name got changed from Sun Techno Overseas Limited to Biogen Pharmachem Industries Limited on March 24,2021. The Company is engaged in the business of trading in shares and securities in present and future market. It trades in commodities, including agro based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates, trades, and sells wind power.

As of March 31, 2009, the Company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets. During the fiscal year ended March 31, 2009 (fiscal 2009), the Company was exploring opportinuities to do the business of import, export and trading in gold, silver and other precious metals, including diamond. The Company is also diversifying its business activities in the power sector, by establishing wind power generation plant.

Company has changed its main objects to Pharmaceutical company dated 8th March 2021.

Parent organization Indian Private
NSE symbol [-]
Founded 1995
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Biogen Pharmachem Industries Ltd?

Answer Field

Biogen Pharmachem Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.91 as on Aug 22 2025 03:29 PM.

What is the Market Cap of Biogen Pharmachem Industries Ltd Share?

Answer Field

The market cap of Biogen Pharmachem Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 83.90 as on Aug 22 2025 03:29 PM.

What is the 52 Week High and Low of Biogen Pharmachem Industries Ltd?

Answer Field

The 52 Week High and Low of Biogen Pharmachem Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1.45 and ₹ 0.75.

What is 1 year return for Biogen Pharmachem Industries Ltd?

Answer Field

The 1 year returns on the stock has been -29.77%.

What is the P/E Ratio of Biogen Pharmachem Industries Ltd Share?

Answer Field

As on Aug 22 2025 03:29 PM the price-to-earnings (PE) ratio for Biogen Pharmachem Industries Ltd share is 92.00.

What is the PB ratio of Biogen Pharmachem Industries Ltd Share?

Answer Field

As on Aug 22 2025 03:29 PM, the price-to-book (PB) ratio for Biogen Pharmachem Industries Ltd share is 1.48.

How to Buy Biogen Pharmachem Industries Ltd Share?

Answer Field

You can trade in Biogen Pharmachem Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Biogen Pharmachem Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Biogen Pharmachem Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Biogen Pharmachem Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91